Skip to main content

Medical Device Outsourcing Market to Worth USD 270.3 Billion by 2030 | Skyquest Technology

Medical Device Outsourcing Market Size, Share, Growth Analysis, By Application – Cardiology, Diagnosis Imaging, Orthopedic, Ophthalmic, and Others, By Service – Contract Manufacturing, Quality Assurance, Product Maintenance Services, and others, By Class – Class I, Class II, and Class III , By Product – Finished Goods, Electronics, Raw Materials), By End User – Small Medical Device Company, Medium Medical Device Company, Large Medical Device Company and Others

Westford, USA, July 03, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the medical device outsourcing market is poised for growth during the forecast period, fueled by the increasing demand for medical devices and the need to address price competition and cost reduction challenges. The healthcare industry continues to witness a surge in demand for advanced medical devices to cater to the evolving needs of patients and healthcare providers.

Browse in-depth TOC on the “Medical Device Outsourcing Market”

  • Pages – 236
  • Tables – 147
  • Figures – 69

Medical device outsourcing market involves delegating manufacturing processes and tasks related to medical devices to external specialized companies. Medical device companies can leverage the expertise and resources of contract manufacturers to efficiently and effectively produce their products, by outsourcing these activities.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/medical-device-outsourcing-market

Report Scope & Segmentation:

AttributesDetails
Market Size in 2022USD 127.4 billion
2030 Value ProjectionUSD 270.3 billion
CAGR12.1%
Forecast Period2023-2030
Segments Covered
  • Application
  • Service
  • Class
  • Product
  • End User
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Prominent Players in the Medical Device Outsourcing Market

  • TÜV SÜD
  • Sterigenics U.S., LLC (GTCR, LLC)
  • Charles River Laboratories
  • Medical Device Testing Services (Element Minnetonka)
  • RJR Consulting, Inc.
  • Mandala International
  • Freyr
  • Global Regulatory Partners
  • Emergo (UL LLC)
  • Bioteknica
  • Accell Clinical Research, LLC
  • Genpact
  • Criterium, Inc.
  • Promedica International
  • Med pace
  • ICON plc.
  • IQVIA Inc.
  • Integer Holdings Corporation
  • Tecomet Inc. (Charles bank Capital Partners, LLC)
  • Jabil Inc.
  • FLEX LTD.
  • Celestica Inc.
  • Sanmina Corporation

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/medical-device-outsourcing-market

Cardiology is Expected to Grow in the Market Due to the High Prevalence of Various Cardiovascular Conditions

The cardiology emerged as the dominant segment in the medical device outsourcing market and is poised to maintain its leading position throughout the forecast period. This can be attributed to the high prevalence of various cardiovascular conditions, including angina pectoris, hypertensive heart disease, atrial fibrillation, and congenital heart disease. These conditions pose significant health challenges globally and require effective diagnosis, treatment, and management.

The markets in the North America is expected to experience the highest CAGR during the forecast period. This can be attributed to several factors. The region is homebased to several well-established manufacturing companies with extensive experience in producing medical devices. These companies benefit from advanced infrastructure, technological expertise, and robust supply chains, enabling them to meet the growing demand for high-end complex medical devices.

Contract Manufacturing Segment is Expected to Dominate the Market Due to the Growing Focus on Cost Reduction

The contract manufacturing segment emerged as the dominant force in the medical device outsourcing market, capturing a substantial market share. This can be attributed to the growing focus on cost reduction in the production of medical devices and the increasing complexity involved in the manufacturing processes. Companies are increasingly turning to contract manufacturers to benefit from their specialized expertise, infrastructure, and economies of scale, allowing them to streamline operations and optimize costs.

Regional markets in the Asia Pacific emerged as the dominant region in the medical device outsourcing market in 2022, capturing a significant market share. The region is poised to maintain its position during the forecast period. This can be attributed to several factors driving the market growth.

A comprehensive analysis of the major players in the medical device outsourcing market has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavours to develop innovative solutions to cater to the growing demand.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/medical-device-outsourcing-market

Key Developments in the Medical Device Outsourcing Market

  • Terumo Aortic, a leading medical device company, recently achieved a significant milestone with the receipt of approval from the U.S. Food and Drug Administration (FDA) for its Relay Pro Thoracic Stent-Graft System. This approval allows Terumo Aortic to market and sell the Relay Pro system in the United States.
  • Laboratory Corporation of America Holdings (LabCorp), a prominent life sciences company, recently moved strategically by acquiring Toxikon Inc., a contract research organization (CRO). This acquisition aimed to enhance LabCorp’s portfolio and capabilities by expanding its range of testing services.

Key Questions Answered in Medical Device Outsourcing Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Diabetic Nephropathy Market

Global Medical Writing Market

Global Medical Imaging Workstations Market

Global Direct-to-Consumer Genetic Testing Market

Global Sickle Cell Disease Treatment Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.